University College London Hospital — London

Public research footprint of University College London Hospital, compiled from the ClinicalTrials.gov public registry.

386

Registered studies

161

Active

Recruiting now

135

Completed

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · Squamous Non Small Cell Lung Cancer (NSCLC-SCC) · Myotonic Dystrophy Type 1 · Relapsed or Refractory Multiple Myeloma (RRMM)

Recently updated registry entries

NCT05291091 — Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) (Active Not Recruiting)
NCT05876754 — An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or… (Active Not Recruiting)
NCT06066580 — Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy (Enrolling By Invitation)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University College London Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.